Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Globus Medical Inc shares valued at $363,353 were sold by Kline Kyle on Jan 08 ’26. At $101.10 per share, Kline Kyle sold 3,594 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, Norwalk Leslie V sold 2,000 shares, netting a total of over 202,200 in proceeds. Following the sale of shares at $101.10 each, the insider now holds 10,419 shares.
Before that, Kline Kyle had added 3,594 shares to its account. In a trade valued at $363,167, the Officer bought Globus Medical Inc shares for $101.05 each.
As published in a research note from Truist on November 07, 2025, Globus Medical Inc [GMED] has been rated up from a Hold to a Buy and the price target has been revised to $93. Analysts at BofA Securities upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in early November. Earlier on May 27, 2025, BTIG Research downgraded its rating. Their new recommendation was “a Neutral” for GMED stock which previously was a “a Buy”.
Analyzing GMED Stock Performance
On last trading session, Globus Medical Inc [NYSE: GMED] rose 1.55% to $93.89. The stock’s lowest price that day was $92.49, but it reached a high of $94.03 in the same session. During the last five days, there has been a drop of approximately -0.77%. Over the course of the year, Globus Medical Inc shares have jumped approximately 6.48%.
Support And Resistance Levels for Globus Medical Inc (GMED)
RSI (Relative Strength Index) is 61.68 on the 14-day chart, showing neutral technical sentiment.
Is Globus Medical Inc subject to short interest?
Stocks of Globus Medical Inc saw a sharp steep in short interest on 2025-12-31 dropping by -0.13 million shares to 4.26 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 4.4 million shares. A decline of -3.16% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.15 of the overall float, the days-to-cover ratio (short ratio) decline to 3.15.
Which companies own the most shares of Globus Medical Inc (GMED)?
In terms of Globus Medical Inc share price expectations, FactSet research, analysts set an average price target of 106 in the next 12 months, up nearly 14.64% from the previous closing price of $92.46. Analysts anticipate Globus Medical Inc stock to reach 115 by 2026, with the lowest price target being 64. In spite of this, 10 analysts ranked Globus Medical Inc stock as Buy at the end of 2026. On January 10, 2025, BofA Securities assigned a price target of “a Neutral” to the stock and upgraded coverage with a $97.
